The American Journal of Managed Care17h
FDA Approves First HER2-Ultralow Companion Diagnostic, Expanding Treatment Eligibility
Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...
FDA approves Datroway for HR-positive, HER2-negative breast cancer
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
Mum shares photo of lump bulging from breast after doctors repeatedly dismissed it – now she’s battling killer cancer
A MUM has shared a shocking photo of a giant lump protruding from her breast, which doctors repeatedly dismissed a benign.